coronavirus vaccine to the AstraZeneca jab.The Joint Committee on Vaccination and Immunisation (JCVI) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced a change to its guidance.
The jab, developed at the University of Oxford, carries with it a slightly increased risk of blood clots (affecting roughly 10 in a million vaccinated people), with an extremely small number proving fatal.
In older age groups the risk is far outweighed by the risk of dying from Covid-19, but for younger people, who are far less likely to become ill and die from the virus, it has been decided that is not the case.
Read more on dailystar.co.uk